You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
MRI in assessment of lung cancer
  1. Bruno Hochhegger1,
  2. Edson Marchiori2,
  3. Klaus Irion3,
  4. Jose Moreira1,
  5. Glaucia Zanetti2
  1. 1Department of Radiology, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil
  2. 2Department of Radiology,Federal University of Rio de Janeiro, Petrópolis, Brazil
  3. 3Department of Radiology,Liverpool Heart and Chest Hospitals, Liverpool, UK
  1. Correspondence to Bruno Hochhegger, Santa Casa de Misericórdia de Porto Alegre, Rua João Alfredo 558/301, Porto Alegre, Brazil; brunohochhegger{at}gmail.com

https://doi.org/10.1136/thx.2011.159111

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We congratulate Fischer et al for their significant and well-written article, published in this issue of Thorax.1 The report covers important topics in the imaging of lung cancer staging. The authors report that positron emission tomography (PET)-CT improves discrimination in metastatic disease. They also demonstrated that patients with enlarged lymph nodes on CT require confirmation independent of PET findings, and that a positive PET-CT finding requires confirmation before making …

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; not externally peer reviewed.